Trial Profile
A RAVAX Phase 3, Multicenter, Switch Assessment of Sequential Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment With Etanercept (ENBREL) or Adalimumab (HUMIRA)
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2013
Price :
$35
*
At a glance
- Drugs Rheumatoid arthritis vaccine (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Immune Response BioPharma
- 12 Dec 2013 New trial record